Net Cash Provided by (Used in) Financing Activities of VERACYTE, INC. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
VERACYTE, INC. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • VERACYTE, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $6,484,000, a 650% decline year-over-year.
  • VERACYTE, INC. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $4,222,000, a 186% decline from 2024.
  • VERACYTE, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4,904,000, a 73% increase from 2023.
  • VERACYTE, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2,837,000, a 19% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

VERACYTE, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $4,222,000 -$9,126,000 -186% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $4,904,000 +$2,067,000 +73% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $2,837,000 -$657,000 -19% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $3,494,000 -$592,826,000 -99% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $596,320,000 +$392,725,000 +193% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $203,595,000 +$76,308,000 +60% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $127,287,000 +$67,788,000 +114% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $59,499,000 +$59,717,000 01 Jan 2018 31 Dec 2018 10-K 22 Feb 2021 2020 FY
2017 $218,000 -$52,547,000 -100% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $52,329,000 +$14,596,000 +39% 01 Jan 2016 31 Dec 2016 10-K 25 Feb 2019 2018 FY
2015 $37,733,000 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY

VERACYTE, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $6,484,000 -$5,620,000 -650% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $864,000 -$2,549,000 -151% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $1,685,000 -$305,000 -15% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $1,990,000 -$589,022,000 -100% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $591,012,000 +$591,231,000 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $219,000 +$8,175,000 +97% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $8,394,000 -$9,295,000 -1032% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $901,000 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.